Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Intestinal lumen water content regulation" is not a single molecular target but rather describes a complex physiological process involving multiple molecular entities that control the movement and balance of water within the intestinal tract. Water movement across the intestinal epithelium occurs primarily in response to osmotic gradients established by active transport of electrolytes and nutrients. Key molecular players include: • **Sodium-glucose cotransporter 1** (*SGLT1*): Mediates secondary active transport by coupling glucose uptake with sodium ions at the apical membrane, facilitating osmotic movement of water into enterocytes[1][4]. • **Cystic fibrosis transmembrane conductance regulator** (*CFTR*): An ATP-binding cassette ion channel that regulates chloride ion secretion into the lumen; its activation draws sodium and thus promotes passive osmotic flow of water[1]. • **Aquaporins** (*AQP* family): Integral membrane proteins forming channels that facilitate rapid transcellular passage of water across enterocyte membranes[3][4]. Several isoforms are expressed in different regions. • **Na+/K+-ATPase**: Maintains electrochemical gradients necessary for secondary active transport processes driving both solute and associated passive paracellular/transcellular movement of water[2]. Water can move via several routes—paracellularly through tight junctions between cells or transcellularly through lipid bilayers, aquaporin channels, or co-transporter complexes like SGLT1. The overall directionality depends on local osmotic forces generated by solute movements. Because "intestinal lumen water content regulation" refers to an integrated physiological function rather than a discrete molecule/receptor/protein/gene product typically considered as a druggable therapeutic target, it is not itself suitable for structured annotation as a canonical therapeutic target. Instead, drugs act on specific components within this system. References from search results indicate that while many drugs indirectly affect this process—for example via modulation of SGLT1 activity during oral rehydration therapy—the term itself does not correspond to any single protein or receptor amenable to direct pharmacological targeting[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal water transport mechanisms.